APRE: Aprea Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Aprea Therapeutics, Inc.

NASDAQ:APRE

SummaryFactSheetFinancial
Price
$0.82
Loss Chance
58.3%
0.92JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
176 / 278
Health Care
540 / 714
United States
?
3,613 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.31
39.65%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.31
39.65%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.27
42.83%
Exelixis
NASDAQ:EXEL
6.93
$50.28
33.50%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Jitta Factors
Growth Opportunity (25)
Recent Business Performance (17)
Financial Strength (23)
Return to Shareholders (0)
Competitive Advantage (17)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Operating MarginDeclined
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.92
100.00%
2.22
137.59%
3.06
159.47%
Biotechnology
5.68
39.65%
5.68
39.65%
6.36
42.83%
COMPANY DESCRIPTION
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
aprea.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.